Apr 29, 2021 11:38AM
Nov 12, 2019 09:03AM
Nov 10, 2019 03:33PM
Sep 30, 2019 09:26AM
Sep 30, 2019 06:12AM
Sep 30, 2019 02:17AM
Aug 6, 2019 07:00AM Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results
Aug 6, 2019 07:00AM
Jul 19, 2019 07:33AM
Jul 19, 2019 07:30AM
Jul 19, 2019 07:30AM
Jul 2, 2019 09:22AM
Jun 27, 2019 09:01AM
Jun 27, 2019 08:09AM Dova Pharmaceuticals (DOVA) Announces FDA Approval of sNDA for DOPTELET for Treatment of Chronic Immune Thrombocytopenia
Jun 27, 2019 08:05AM
Jun 27, 2019 08:05AM
Jun 25, 2019 08:04AM
Jun 25, 2019 08:00AM
Jun 25, 2019 08:00AM
May 7, 2019 07:00AM
May 7, 2019 07:00AM Dova Pharmaceuticals Reports First Quarter 2019 Operating and Financial Results
Apr 29, 2019 07:31AM
Apr 29, 2019 07:30AM
Apr 29, 2019 07:30AM
Mar 5, 2019 07:00AM
Mar 5, 2019 07:00AM
Dec 20, 2018 07:08AM
Nov 8, 2018 04:05PM Dova Pharmaceuticals Reports Third Quarter 2018 Operating and Financial Results
Nov 8, 2018 04:05PM
Nov 5, 2018 07:10AM
Nov 5, 2018 07:00AM
Nov 5, 2018 07:00AM
Sep 27, 2018 11:57AM
Sep 27, 2018 11:57AM
Sep 27, 2018 07:47AM Dova Pharmaceuticals (DOVA) Announces Co-Promotion Pact with Salix Pharmaceuticals for DOPTELET (Avatrombopag)
Sep 27, 2018 07:45AM
Sep 27, 2018 07:45AM
Sep 11, 2018 04:45PM
Sep 11, 2018 04:45PM
Sep 5, 2018 09:18AM
Sep 4, 2018 06:42PM
Sep 4, 2018 04:13PM Dova Pharmaceuticals (DOVA) Reports Submission of Supplemental New Drug Application for DOPTELET (avatrombopag) for Treatment of Chronic ITP
Sep 4, 2018 04:05PM
Sep 4, 2018 04:05PM
Aug 9, 2018 04:01PM
Aug 9, 2018 04:01PM
Jun 4, 2018 07:04AM
Jun 4, 2018 07:00AM
Jun 4, 2018 07:00AM Dova Pharmaceuticals Announces Publication of Pivotal Phase 3 Data and Upcoming Congress Presentations for DOPTELET® (avatrombopag)
May 31, 2018 07:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All